https://www.selleckchem.com/pr....oducts/trastuzumab-d
However, current tools have limitations. The CISNE score model is useful to support decision-making, especially for patients with stable FN. (4) There are still some challenges, including the benefits of granulocyte colony stimulating factor treatment and the optimal antibiotic regimen in emergency management of FN. In view of the current reports, our group discusses the key points, new challenges, and management of CIN.As the most populous country in the world, China has made strides in health promotion in the past few d